Does adjuvant systemic therapy with interferon-alpha for stage II-III melanoma prolong survival?

Lex Eggermont, CJA Punt

Research output: Contribution to journalArticleAcademic

18 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)531-536
Number of pages6
JournalAmerican Journal of Clinical Dermatology
Volume4
Issue number8
DOIs
Publication statusPublished - 2003

Research programs

  • EMC MM-03-47-11

Cite this